Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: A double-blind, placebo-controlled, randomised, factorial cross-over study

British Journal of Nutrition

Volumn 111, Issue 11, 2014, Pages 1945-1956

  Childs, Caroline E ^a,b   Röytiö, Henna ^c,d   Alhoniemi, Esa ^e   Fekete, Agnes A ^a   Forssten, Sofia D ^c   Hudjec, Natasa ^a   Lim, Ying Ni ^a   Steger, Cara J ^a   Yaqoob, Parveen ^a   Tuohy, Kieran M ^a,f   Rastall, Robert A ^a   Ouwehand, Arthur C ^c   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c Active Nutrition DuPont Nutrition and Health   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e Pharmatest Services Ltd   (Finland)

^f RESEARCH AND INNOVATION CENTRE   (Italy)

Author keywords

Gut microbiota; Immune function; Pre , pro and synbiotics

Indexed keywords

ANALGESIC AGENT; CD16 ANTIGEN; CD19 ANTIGEN; CD56 ANTIGEN; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MALTODEXTRIN; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; XYLO OLIGOSACCHARIDE; BIOLOGICAL MARKER; GLUCURONIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIGOSACCHARIDE; TRIACYLGLYCEROL; XYLOOLIGOSACCHARIDE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BACTERIAL COUNT; BACTERIAL GROWTH; BIFIDOBACTERIUM ANIMALIS; BLOATING; COLONY FORMING UNIT; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEFECATION HABIT; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FLATULENCE; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; INTESTINE MOTILITY; LIPID BLOOD LEVEL; MALE; MOOD; NATURAL KILLER T CELL; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; ADAPTIVE IMMUNITY; ATOPOBIUM; BODY MASS; CLOSTRIDIUM; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM PERFRINGENS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HEADACHE; HUMAN EXPERIMENT; IMMUNE RESPONSE; INNATE IMMUNITY; LACTOBACILLUS; LYMPHOCYTE COUNT; MUCOSAL IMMUNITY; OLIGONUCLEOTIDE PROBE; PHAGOCYTOSIS; PREVOTELLA; PROTEIN EXPRESSION; PROTEIN SECRETION; QUESTIONNAIRE; BIFIDOBACTERIUM; BLOOD; CHEMISTRY; DEFECATION; FECES; GASTROINTESTINAL TRACT; IMMUNE SYSTEM; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

ADULT; BIFIDOBACTERIUM; BIOMARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COLONY COUNT, MICROBIAL; CROSS-OVER STUDIES; DEFECATION; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GLUCURONATES; HEALTHY VOLUNTEERS; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN A; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; SURVEYS AND QUESTIONNAIRES; SYNBIOTICS; TRIGLYCERIDES;

EID: 84900505942     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513004261     Document Type: Article

References (48)

1. Gibson GR Scott KP Rastall RA et al. (2010) Dietary prebiotics: Current status and new definition. Food Sci Technol Bull Funct Foods 7 1-19.
2. Imaizum i K Nakatsu Y Sato M et al. (1991) Effects of xylooligosaccharides on blood-glucose serum and liver lipids and cecum short-chain fatty-acids in diabetic rats. Agr Biol Chem Tokyo 55 199-205.
3. KogaK&Fujikawa S (1993) Xylooligosaccharides. In Oligosaccharides: Production Properties and Applications Japanese Technology Reviews 1st ed. pp. 130-143 [T Nakakuki editor]. Philadelphia PA: Gordon and Breach Science Pu blishers.
4. Jaskari J Kontula P Siitonen A et al. (1998) Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl Microbiol Biotechnol 49 175-181.
5. Kontula P von Wright A & Mattila-Sandholm T (1998) Oat bran beta-gluco-and xylo-oligosaccharides as fermentative substrates for lactic acid bacteria. Int J Food Microbiol 45 1 63-169.
6. Yong X Hua J Quiang Y et al. (2001) The ability of XOS to promote the proliferation of Bifidobacterium adolescentis. Food Sci 22 15-17.
7. Crittenden R Karppinen S Ojanen S et al. (2002) In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J Sci Food Agr 82 781-789.
8. Palframan RJ Gibson GR & Rastall RA (2003) Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr Issues Intest Microbiol 4 71-75.
9. Makelainen H Saarinen M Stowell J et al. (2010) Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. Benef Microbes 1 139-148.
10. Rycroft CE Jones MR Gibson GR et al. (2001) A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91 878-887.
11. Zampa A Silvi S Fabiani R et al. (2004) Effects of different digestible carbohydrates on bile acid metabolism and SCFA production by human gut micro-flora grown in an in vitro semi-continuous culture. Anaerobe 10 19-26.
12. Makelainen H Forssten S Saarinen M et al. (2010) Xylooligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model. Benef Microbes 1 81-9 1.
13. Campbell JM Fahey GC Jr. & Wolf BW (1997) Selected indigestible oligosaccharides affect large bowel mass cecal and fecal short-chain fatty acids pH and microflora in rats. J Nutr 127 13 0-136.
14. Hsu CK Liao JW Chung YC et al. (2004) Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 134 1523-1528.
15. Santos A San Mauro M & Diaz DM (2006) Prebiotics and their long-term influence on the microbial populations of the mouse bowel. Food Microbiol 23 498-503.
16. Nakakuki T 2003 Development of functional oligosaccharides in Japan Trends Glycosci Glyctechnol 15 57-64.
17. Okazaki M Fujikawa S & Matsumoto M (1990) Effect of xylooligosaccharide on the growth of bifidobacteria. Bifidobact Microflora 9 77-86.
18. Lecerf JM Depeint F Clerc E et al. (2012) Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects while XOS alone only shows prebiotic properties. Br J Nutr 108 1847-1858.
19. Iino T Nishijima Y Sawada S et al. (1997) Improvement of constipation by a small amount of XOS ingestion in adult women. J Jap Assoc Dietary Fiber Res 1 19-24.
20. Tateyama I Hashii K Johno I et al. (2005) Effect of xylooligosaccharide intake on severe constipation in pregnant women. J Nutr Sci Vitaminol (Tokyo) 51 445-448.
21. Gibson GR Probert HM Loo JV et al. (2004) Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev 17 259-275.
22. Roberfroid M (2007) Prebiotics: The concept revisited. J Nutr 137 830S-837S.
23. Roberfroid M Gibson GR Hoyles L et al. (2010) Prebiotic effects: Metabolic and health benefits. Br J Nutr 104 S1-S63.
24. Ebersbach T Jorgensen JB Heegaard PM et al. (2010) Certain dietary carbohydrates promote Listeria infection in a guinea pig model while others prevent it. Int J Food Microbiol 140 218-224.
25. Ebersbach T Andersen JB Bergstrom A et al. (2012) Xylooligosaccharides inhibit pathogen adhesion to enterocytes in vitro. Res Microbiol 163 22-27.
26. Lomax AR & Calder PC (2009) Probiotics immune function infection and inflammation: A review of the evidence from studies conducted in humans. Curr Pharm Des 15 1428-1518.
27. Ringel-Kulka T Palsson OS Maier D et al. (2011) Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: A double-blind study. J Clin Gastroenterol 45 518-525.
28. Leyer GJ Li S Mubasher ME et al. (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124 e172-e179.
29. Rastall RA & Maitin V (2002) Prebiotics and synbiotics: Towards the next generation. Curr Opin Biotechnol 13 490-496.
30. Erdfelder E Faul F & Buchner A (1996) GPOWER: A general power analysis program. Behav Res Methods Instrum Comput 28 1-11.
31. Gill HS Rutherfurd KJ Cross ML et al. (2001) Enhancement of immunity in the elderly by dietary supplementation wi th the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74 833-839.
32. Roessler A Friedrich U Vogelsang H et al. (2008) The immune system in healthy adults and patients with atopic der matitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 38 93-102.
33. Seidel C Boehm V Vogelsang H et al. (2007) Influence of prebiotics and antioxidants in br ead on the immune system antioxidative status and antioxidative capacity in male smokers and non-smokers. Br J Nutr 97 349-356.
34. Roller M Clune Y Collins K et al. (2007) Consumption of pr ebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr 97 67 6-684.
35. Kang M Ragan BG & Park JH (2008) Issues in outcomes research: An overview of randomization techniques for clinical trials. J Athl Train 43 215-221.
36. Costabile A Kolida S Klinder A et al. (2010) A doubleblind placebo-controlled cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in hea lthy human subjects. Br J Nutr 104 1007-1017.
37. Ventura M Reniero R Zink R 2001 Specific identification and targeted characterization of Bifidobacterium lactis from different environmenta l isolates by a combined multiplex-PCR approach Appl Environ Microbiol 67 2760-2765.
38. Apajalahti JH Kettunen H Kettunen A et al. (2002) Cultureindependent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl Enviro n Microbiol 68 4986-4995.
39. Richardson AJ Calder AG Stewart CS et al. (1989) Simultaneous determination of volatile and non-volatile acidic fermentation products of anaerobes by capillary gas-ch romatography. Lett Appl Microbiol 9 5-8.
40. Costabile A Fava F Roytio H et al. (2012) Impact of polydextrose on the faecal microbiota: A double-blind crossover placebo-controlled feeding study in healthy human subjects. Br J Nutr 108 471-481.
41. Hothorn T Bretz F & Westfall P (2008) Simultaneous inference in general parametric models. Biom J 50 346-363.
42. Shepherd J (2005) Raising HDL-cholesterol and lowering CHD risk: Does intervention work Eur Heart J 7 F15-F22.
43. Gordon DJ Probstfield JL Garrison RJ et al. (1989) Hig hdensity lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 8-15.
44. Delzenne NM & Williams CM (2002) Prebiotics and lipid metabolism. Curr Opin Lipidol 13 61-67.
45. Ooi L-G & Liong M-T (2010) Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. In J Mol Sci 11 2499-2522.
46. Lomax AR & Calder PC (2009) Prebiotics Immune function infection and inflammation: A review of the evidence. Br J Nutr 101 633-658.
47. Bermudez-Brito M Plaza-D́az J Munoz Quezada S et al. (2012) Probiotic mechanisms of action. Ann Nutr Metab 61 160-174.
48. Albers R Antoine JM Bourdet-Sicard R et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94 452-481.